Peihan Li
About Peihan Li
Peihan Li is a Senior Manager in Pharmacovigilance at BeiGene in Shanghai, with over a decade of experience in the field and a strong background in clinical data management, biotechnology, and bioscience.
Title
Peihan Li is currently a Senior Manager in Pharmacovigilance at BeiGene, located in Shanghai, China.
Professional Background and Experience
With over a decade of experience in the pharmacovigilance field, Peihan Li has held multiple roles in different esteemed organizations. Before his current role at BeiGene, he worked as Pharmacovigilance Manager at Fosun Kite. Prior to that, he built his career at IQVIA, where he held positions such as Senior Operations Specialist and Operations Specialist Manager from 2012 to 2018 in Shanghai, and Associate Operation Specialist in Dalian, Liaoning. His career also included a brief tenure as Pharmacovigilance Manager at Fosun Kite in 2018.
Education and Expertise
Peihan Li studied at the University of Leeds, where he earned a Master's degree in Bioscience between 2010 and 2011. Prior to his Master's, he completed a Bachelor of Science (B.Sc.) in Pharmacology at the same institution from 2007 to 2010. This academic background laid a foundation that complemented his profound expertise in clinical data management, biotechnology, and bioscience.
Company - BeiGene
BeiGene, where Peihan Li currently works, is a renowned global biotechnology company focusing on molecularly targeted and immuno-oncology drug discovery. Peihan Li’s role as Senior Manager in Pharmacovigilance involves overseeing safety surveillance processes, ensuring the effective monitoring of drug safety, and maintaining compliance with international regulatory standards.
Clinical Data Management Expertise
Throughout his career, Peihan Li has demonstrated strong capabilities in clinical data management. His role at IQVIA significantly developed his skills in this area, preparing him for higher responsibilities and complex scenarios in pharmacovigilance. This expertise is crucial in his current role at BeiGene, supporting the company's mission to develop precise and effective treatments.